Low-affinity kainate receptor-mediated events reduce the protective activity of phenobarbital and diphenylhydantoin against maximal electroshock in mice

Neuropharmacology

Volumn 43, Issue 7, 2002, Pages 1082-1086

  Borowicz, K K ^a   Zadrozniak, M ^a   Czuczwar, S J ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Kainate agonists; Low affinity kainate receptors; Maximal electroshock; Seizures; SYM 2081

Indexed keywords

4 METHYLGLUTAMIC ACID; CARBAMAZEPINE; DIAZEPAM; KAINIC ACID RECEPTOR AGONIST; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; ELECTRIC CURRENT; ELECTRIC SHOCK; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SEIZURE THRESHOLD; TONIC CLONIC SEIZURE;

EID: 0036909379     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00286-1     Document Type: Article

References (28)

1. Bailey A., Kelland E.E., Thomas A., Biggs J., Crawford D., Kitchen I., Toms N.J. Regional mapping of low-affinity kainate receptors in mouse brain using [(3)H](2S,4R)-4-methylglutamate autoradiography. European Journal of Pharmacology. 431:2001;305-310.
2. Bettler B., Mulle C. Review: Neurotransmitter receptors II. AMPA and kainate receptors. Neuropharmacology. 34:1995;123-139.
3. Carlson H., Ronne-Engstrom E., Ungerstedt U., Hillered L. Seizure-related elevations of extracellular amino acids in human focal epilepsy. Neuroscience Letters. 140:1992;30-32.
4. Carroll F.Y., Finkelstein D.I., Horne M.K., Lawrence A.J., Crawford D., Paxinos G., Beart P.M. Regional distribution of low affinity kainate receptors in brain of Macaca fascicularis determined by autoradiography using [3H](2S,4R)-4-methylglutamate. Neuroscience Letters. 16:1998;71-74.
5. Czuczwar S.J., Frey H.H., Löscher W. Antagonism of N-methyl-D,L-aspartate acid-induced convulsions by antiepileptic drugs and other agents. European Journal of Pharmacology. 108:1985;273-280.
6. Deckers C.L., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., Patsalos P.N., Renier W.O., Van Rijn C.M. Selection of antiepileptic drug polytherapy based on mechanisms of action; the evidence reviewed. Epilepsia. 41:2000;1364-1374.
7. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet. 342:1993;1607-1610.
8. 2 inhibitors. Brain Research Reviews. 38:2001;61-78.
9. Giardina S.F., Beart P.M. Excitotoxic profiles of novel, low-affinity kainate receptor agonists in primary cultures of murine cerebellar granule cells. Neuropharmacology. 41:2001;421-432.
10. Hakkarainen H. Carbamazepine versus phenytoin vs their combination in refractory epilepsy. Neurology. 30:1980;354.
11. Hamberger A.C., Nystrom B., Larsson S., Silfvenius H., Nordborg C. Amino acids in the neuronal microenvironment of focal human epileptic lesions. Epilepsy Research. 9:1991;32-43.
12. Janjua N.A., Itano K., Kugoh T., Hosokawa K., Nakano M., Matsui H., Hatase O. Familial increase in plasma glutamic acid in epilepsy. Epilepsy Research. 11:1992;37-44.
13. Jones K.A., Wilding T.J., Huettner J.E., Costa A.M. Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate. Neuropharmacology. 36:1997;853-863.
14. + currents: quantitative distinction from phenytoin and possible therapeutic implications. Molecular Pharmacology. 51:1997;1077-1083.
15. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. Journal of Pharmacology and Experimental Therapeutics. 96:1949;99-113.
16. Löscher W., Rundfeldt. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and non-resistant rats. Journal of Pharmacology and Experimental Therapeutics. 258:1991;483-489.
17. Mattson R.H., Cramer J.A., Collins J.F., Smith D.B., Delgado-Escueta A.V., Browne T.R., Williamson P.D., Treinan D.M., McNamara J.O., McCutchen C.B., et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New England Journal of Medicine. 313:1985;145-151.
18. Parsons C.G., Danysz W., Quack G. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspectus. 11:1998;523-569.
19. Pilip S., Urbanska E.M., Swiader M., Wlodarczyk D., Kleinrok Z., Czuczwar S.J., Turski W.A. Anticonvulsant action of chlormethiazole is prevented by subconvulsive amounts of strychnine and aminophylline but not by bicuculline and picrotoxin. Polish Journal of Pharmacology. 52:2000;267-273.
20. Rogawski M.A., Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacological Reviews. 42:1990;223-286.
21. Savidge J.R., Sturgess N.C., Bristow D.R., Lock E.A. Characterization of kainate receptor mediated whole-cell currents in rat cultured cerebellar granule cells. Neuropharmacology. 38:1999;375-382.
22. Small B., Thomas J., Kemp M., Hoo K., Ballyk B., Deverill M., Ogden A.M., Rubio A., Pedegral C., Bleakman D. LY 339434, a GluR5 kainate receptor agonist. Neuropharmacology. 37:1998;1261-1267.
23. Song J.H., Nagata K., Huang C.S., Yeh J.Z., Narahashi T. Differential block of two types of sodium channels by anticonvulsants. Neuroreport. 25:1996;3031-3036.
24. Steppuhn K.G., Turski L. Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. Journal of Pharmacology and Experimental Therapeutics. 265:1993;1063-1068.
25. 3H]-(2S,2R)-4-methylglutamate: pharmacological characterization in rabbit brain membranes. Neuropharmacology. 36:(-1488):1997;14-83.
26. Urbanska E.M., Tomczyk T., Haberek G., Pilip S., Matyska J., Turski W.A., Kleinrok Z., Czuczwar S.J. NMDA- but not kainate-mediated events reduce efficacy of some antiepileptic drugs against generalized tonic-clonic seizures in mice. Epilepsia. 40:1999;1507-1511.
27. Vreugdenhil M., Wadman W.J. Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis. Epilepsia. 40:1999;1512-1527.
28. White H.S. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia. 38:1997;S9-S17.